Terms: = Leukemia AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Diagnosis
20 results:
1. Small cell variant anaplastic large cell lymphoma presenting as leukemia: A case report and review of Literature.
Dutta R; Ramteke P; Mathur SR; Saxena R; Pati HP; Mallick S
Indian J Pathol Microbiol; 2022; 65(3):705-708. PubMed ID: 35900509
[TBL] [Abstract] [Full Text] [Related]
2. What to use to treat AML: the role of emerging therapies.
Thol F
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359
[TBL] [Abstract] [Full Text] [Related]
3. Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.
Fajgenbaum DC; Wu D; Goodman A; Wong R; Chadburn A; Nasta S; Srkalovic G; Mukherjee S; Leitch H; Jayanthan R; Ferrero S; Sato Y; Schey S; Dispenzieri A; Oksenhendler E; Zinzani PL; Lechowicz MJ; Hoffmann C; Pemmaraju N; Bagg A; Fossa A; Lim MS; van Rhee F;
Am J Hematol; 2020 Dec; 95(12):1553-1561. PubMed ID: 32894785
[TBL] [Abstract] [Full Text] [Related]
4. Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor.
Taverna L; Tremolada M; Bonichini S; Tosetto B; Basso G; Messina C; Pillon M
PLoS One; 2017; 12(10):e0186787. PubMed ID: 29065156
[TBL] [Abstract] [Full Text] [Related]
5. Novel targets in the treatment of chronic graft-versus-host disease.
Im A; Hakim FT; Pavletic SZ
Leukemia; 2017 Mar; 31(3):543-554. PubMed ID: 27899803
[TBL] [Abstract] [Full Text] [Related]
6. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative ultrasound at the hand phalanges in patients with bisphosphonate-related osteonecrosis of the jaws.
Motta AC; de Macedo LD; Santos GG; Guerreiro CT; Ferrari T; de Oliveira TF; Santos PS; de Oliveira-Santos C; Ricz HM; Xavier SP; Iannetta O
Braz Oral Res; 2015; 29(1):S1806-83242015000100301. PubMed ID: 26892357
[TBL] [Abstract] [Full Text] [Related]
8. Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease diagnosis.
Brooks SE; Bonney SA; Lee C; Publicover A; Khan G; Smits EL; Sigurdardottir D; Arno M; Li D; Mills KI; Pulford K; Banham AH; van Tendeloo V; Mufti GJ; Rammensee HG; Elliott TJ; Orchard KH; Guinn BA
PLoS One; 2015; 10(10):e0140483. PubMed ID: 26492414
[TBL] [Abstract] [Full Text] [Related]
9. The choice of first-line chronic myelogenous leukemia treatment.
Fava C; Rege-Cambrin G; Saglio G
Ann Hematol; 2015 Apr; 94 Suppl 2(Suppl 2):S123-31. PubMed ID: 25814078
[TBL] [Abstract] [Full Text] [Related]
10. [Granulocytic sarcoma of the femur in a patient with acute megakaryoblastic leukaemia].
Čolović N; Bogdanović A; Vidović A; Perunčić-Jovanović M; Čolović M
Srp Arh Celok Lek; 2011; 139(11-12):805-8. PubMed ID: 22338480
[TBL] [Abstract] [Full Text] [Related]
11. Epithelial-myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features.
Angiero F; Sozzi D; Seramondi R; Valente MG
Anticancer Res; 2009 Nov; 29(11):4703-9. PubMed ID: 20032423
[TBL] [Abstract] [Full Text] [Related]
12. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract] [Full Text] [Related]
13. Morphological spectrum of AIDS-related plasmablastic lymphomas.
Gujral S; Shet TM; Kane SV
Indian J Pathol Microbiol; 2008; 51(1):121-4. PubMed ID: 18417882
[TBL] [Abstract] [Full Text] [Related]
14. Epithelial membrane antigen (ema) or muc1 expression in monocytes and monoblasts.
Leong CF; Raudhawati O; Cheong SK; Sivagengei K; Noor Hamidah H
Pathology; 2003 Oct; 35(5):422-7. PubMed ID: 14555387
[TBL] [Abstract] [Full Text] [Related]
15. Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.
Robak T; Urbańska-Rys H; Robak E; Bartkowiak J; Strzelecka B; Biernat W; Kordek R
Leuk Lymphoma; 2002 May; 43(5):1067-73. PubMed ID: 12148888
[TBL] [Abstract] [Full Text] [Related]
16. t(2;5) associated with a histiocytic-monocytic neoplasm.
Lemes A; De La Iglesia S; Santana C; Cigudosa JC; Matutes E; Molero T
Leuk Lymphoma; 2001 Apr; 41(3-4):429-33. PubMed ID: 11378558
[TBL] [Abstract] [Full Text] [Related]
17. Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features.
Hodges KB; Collins RD; Greer JP; Kadin ME; Kinney MC
Am J Surg Pathol; 1999 Jan; 23(1):49-58. PubMed ID: 9888703
[TBL] [Abstract] [Full Text] [Related]
18. Results with the ema/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract] [Full Text] [Related]
19. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
Falini B; Pileri S; Stein H; Dieneman D; Dallenbach F; Delsol G; Minelli O; Poggi S; Martelli MF; Pallesen G
Hum Pathol; 1990 Jun; 21(6):624-9. PubMed ID: 1693592
[TBL] [Abstract] [Full Text] [Related]
20. Histology and immunohistology of bone marrow biopsy in multiple myeloma.
Pileri S; Poggi S; Baglioni P; Montanari M; Sabattini E; Galieni P; Tazzari PL; Gobbi M; Cavo M; Falini B
Eur J Haematol Suppl; 1989; 51():52-9. PubMed ID: 2627992
[TBL] [Abstract] [Full Text] [Related]
